In the case of BPC-157, compounders obtain the raw peptide (synthesized via solid-phase chemical synthesis) and then prepare it into injectable vials, nasal sprays, or capsules per a doctors prescription. Clinics and online research chemical websites also sell BPC-157 directly to consumers, often labeling it for research use only to skirt regulations
However, individuals with diabetes should work closely with healthcare providers, as the compound may affect blood sugar levels and require medication adjustments
Doses and ingredients could be different to whats on the label, and theres risk of contamination
Do not administer this drug to the following patients: 1) Patients with hypersensitivity to the components of this drug 2) Patients with hypercalcemia, hypercalciuria 3) Patients with calcium oxalate stones 4) Patients with renal impair 5) Patients who are immobilized in a hospital bed 6) Sarcoidosis 7) Patients with pseudoparathyroidism 3
Peptide therapy is not a cure-all